These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 9773222

  • 21. Alprazolam and standard antidepressants in the treatment of depression: a meta-analysis of the antidepressant effect.
    Srisurapanont M, Boonyanaruthee V.
    J Med Assoc Thai; 1997 Mar; 80(3):183-8. PubMed ID: 9175386
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis.
    Offidani E, Guidi J, Tomba E, Fava GA.
    Psychother Psychosom; 2013 Mar; 82(6):355-62. PubMed ID: 24061211
    [Abstract] [Full Text] [Related]

  • 23. A case report of alprazolam-induced stuttering.
    Elliott RL, Thomas BJ.
    J Clin Psychopharmacol; 1985 Jun; 5(3):159-60. PubMed ID: 2860135
    [Abstract] [Full Text] [Related]

  • 24. Treatments for generalized anxiety disorder.
    Struzik L, Vermani M, Coonerty-Femiano A, Katzman MA.
    Expert Rev Neurother; 2004 Mar; 4(2):285-94. PubMed ID: 15853570
    [Abstract] [Full Text] [Related]

  • 25. Generalised anxiety disorder: treatment options.
    Sramek JJ, Zarotsky V, Cutler NR.
    Drugs; 2002 Mar; 62(11):1635-48. PubMed ID: 12109925
    [Abstract] [Full Text] [Related]

  • 26. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 27. Management of mixed anxiety and depression.
    Degruy F.
    Am Fam Physician; 1994 Mar; 49(4):860-6. PubMed ID: 7906917
    [Abstract] [Full Text] [Related]

  • 28. Drug treatment of panic disorder--a critical review of controlled clinical trials.
    Balestrieri M, Ruggeri M, Bellantuono C.
    Psychiatr Dev; 1989 Mar; 7(4):337-50. PubMed ID: 2577301
    [Abstract] [Full Text] [Related]

  • 29. Paroxetine efficacy in the treatment of generalized anxiety disorder.
    Rocca P, Fonzo V, Scotta M, Zanalda E, Ravizza L.
    Acta Psychiatr Scand; 1997 May; 95(5):444-50. PubMed ID: 9197912
    [Abstract] [Full Text] [Related]

  • 30. The pharmacologic treatment of anxiety disorders: a review of progress.
    Ravindran LN, Stein MB.
    J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
    [Abstract] [Full Text] [Related]

  • 31. Psychopharmacologic treatment of anxiety disorders in adolescents and children.
    Popper CW.
    J Clin Psychiatry; 1993 May; 54 Suppl():52-63. PubMed ID: 8099578
    [Abstract] [Full Text] [Related]

  • 32. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    Jonas JM, Cohon MS.
    J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
    [Abstract] [Full Text] [Related]

  • 33. Clinical pharmacology of anxiolytics and antidepressants: a psychopharmacological perspective.
    Nutt DJ, Glue P.
    Pharmacol Ther; 1989 Oct; 44(3):309-34. PubMed ID: 2577512
    [No Abstract] [Full Text] [Related]

  • 34. An effect-size analysis of pharmacologic treatments for generalized anxiety disorder.
    Hidalgo RB, Tupler LA, Davidson JR.
    J Psychopharmacol; 2007 Nov; 21(8):864-72. PubMed ID: 17984162
    [Abstract] [Full Text] [Related]

  • 35. The diagnosis and treatment of generalized anxiety disorder.
    Bandelow B, Boerner J R, Kasper S, Linden M, Wittchen HU, Möller HJ.
    Dtsch Arztebl Int; 2013 Apr; 110(17):300-9; quiz 310. PubMed ID: 23671484
    [Abstract] [Full Text] [Related]

  • 36. Generalized anxiety disorder: comorbidity, comparative biology and treatment.
    Nutt DJ, Ballenger JC, Sheehan D, Wittchen HU.
    Int J Neuropsychopharmacol; 2002 Dec; 5(4):315-25. PubMed ID: 12466031
    [Abstract] [Full Text] [Related]

  • 37. A review of the efficacy and tolerability of immediate-release and extended-release formulations of gepirone.
    Robinson DS, Sitsen JM, Gibertini M.
    Clin Ther; 2003 Jun; 25(6):1618-33. PubMed ID: 12860488
    [Abstract] [Full Text] [Related]

  • 38. Predictors of persistence of comorbid generalized anxiety disorder among veterans with major depressive disorder.
    Mittal D, Fortney JC, Pyne JM, Wetherell JL.
    J Clin Psychiatry; 2011 Nov; 72(11):1445-51. PubMed ID: 21208594
    [Abstract] [Full Text] [Related]

  • 39. Serotonin-1A anxiolytics: an overview.
    Feighner JP, Boyer WF.
    Psychopathology; 1989 Nov; 22 Suppl 1():21-6. PubMed ID: 2567039
    [Abstract] [Full Text] [Related]

  • 40. Generalised anxiety disorder in elderly patients : epidemiology, diagnosis and treatment options.
    Flint AJ.
    Drugs Aging; 2005 Nov; 22(2):101-14. PubMed ID: 15733018
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.